Z. Shi

The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review.

Shu Cheng, Ruiqi Huang, Xiaopeng Ma, 2022, Clinical lymphoma, myeloma & leukemia.

Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study.

Shu Cheng, Li Wang, Jian-Feng Li, 2022, The Lancet. Healthy longevity.

EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

Zheng Ma, Depei Huang, Zi-Yang Shi, 2022, Frontiers in Oncology.

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma

Li Wang, P. Xu, Q. Shi, 2023, Signal Transduction and Targeted Therapy.